| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
111,543 |
92,834 |
$21.49M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
123,576 |
103,751 |
$1.86M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
9,916 |
8,153 |
$1.52M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,367 |
16,845 |
$380K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28,470 |
24,560 |
$373K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,453 |
5,043 |
$293K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
4,183 |
2,647 |
$253K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,364 |
1,317 |
$235K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,467 |
17,573 |
$221K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,828 |
3,814 |
$142K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,668 |
1,627 |
$91K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,642 |
3,632 |
$86K |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
474 |
471 |
$77K |
| 59425 |
|
1,195 |
709 |
$55K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,642 |
1,638 |
$49K |
| 99215 |
Prolong outpt/office vis |
1,044 |
1,028 |
$48K |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
2,211 |
2,144 |
$48K |
| J3490 |
Unclassified drugs |
3,203 |
3,162 |
$45K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
13,177 |
10,724 |
$44K |
| 87486 |
|
2,104 |
2,037 |
$40K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
615 |
615 |
$39K |
| 87581 |
|
2,104 |
2,037 |
$39K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,082 |
2,041 |
$39K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,251 |
1,251 |
$38K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,061 |
1,058 |
$28K |
| 90686 |
|
1,635 |
1,635 |
$23K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,180 |
1,175 |
$20K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,348 |
3,911 |
$19K |
| 99000 |
|
10,088 |
9,308 |
$18K |
| H1000 |
Prenatal care, at-risk assessment |
144 |
144 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,890 |
1,879 |
$17K |
| 82948 |
|
12,166 |
10,209 |
$17K |
| 81003 |
|
19,596 |
14,833 |
$17K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
385 |
385 |
$16K |
| 80053 |
Comprehensive metabolic panel |
2,672 |
2,656 |
$15K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
466 |
462 |
$14K |
| 80061 |
Lipid panel |
1,915 |
1,909 |
$14K |
| 59430 |
|
217 |
217 |
$13K |
| 99188 |
|
1,607 |
1,606 |
$13K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
962 |
922 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
371 |
362 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,684 |
2,671 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,809 |
1,803 |
$10K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,558 |
1,474 |
$9K |
| 92552 |
|
1,175 |
1,173 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
268 |
256 |
$9K |
| 84480 |
|
1,190 |
1,183 |
$9K |
| 81025 |
|
4,721 |
4,590 |
$9K |
| 84439 |
|
1,644 |
1,636 |
$8K |
| 51798 |
|
1,049 |
1,034 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,200 |
1,159 |
$6K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,210 |
1,116 |
$5K |
| 86580 |
|
2,749 |
2,739 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,075 |
1,018 |
$4K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
230 |
221 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
405 |
390 |
$4K |
| 87428 |
|
67 |
67 |
$4K |
| 82607 |
|
530 |
526 |
$3K |
| 83655 |
|
628 |
626 |
$3K |
| 99243 |
|
38 |
38 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
260 |
249 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
285 |
284 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
68 |
68 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
27 |
27 |
$2K |
| 99173 |
|
1,209 |
1,209 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
129 |
128 |
$2K |
| 99381 |
|
63 |
63 |
$1K |
| 20610 |
|
98 |
93 |
$1K |
| 0259 |
|
103 |
101 |
$986.51 |
| 85018 |
|
813 |
809 |
$927.13 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
179 |
148 |
$926.82 |
| 85014 |
|
645 |
642 |
$681.01 |
| 81001 |
|
154 |
150 |
$651.64 |
| 0250 |
|
66 |
61 |
$624.33 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
137 |
137 |
$605.73 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
109 |
105 |
$586.97 |
| 81000 |
|
307 |
265 |
$503.85 |
| 82728 |
|
70 |
69 |
$473.34 |
| 86738 |
|
39 |
39 |
$431.40 |
| 20550 |
|
26 |
24 |
$309.09 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
54 |
52 |
$269.18 |
| 87186 |
|
26 |
25 |
$159.05 |
| 87077 |
|
14 |
13 |
$67.92 |
| 3008F |
|
654 |
579 |
$50.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
159 |
148 |
$22.26 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
256 |
253 |
$4.46 |
| 3077F |
|
282 |
268 |
$0.00 |
| 1159F |
|
733 |
646 |
$0.00 |
| 99442 |
|
188 |
186 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,267 |
3,241 |
$0.00 |
| 90461 |
|
1,824 |
1,817 |
$0.00 |
| 82652 |
|
39 |
39 |
$0.00 |
| 1160F |
|
726 |
642 |
$0.00 |
| 3078F |
|
724 |
664 |
$0.00 |
| 1033F |
|
182 |
165 |
$0.00 |
| 4145F |
|
118 |
104 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
16 |
14 |
$0.00 |
| 4013F |
|
197 |
177 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,259 |
1,250 |
$0.00 |
| Z1034 |
|
4,977 |
3,321 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
116 |
116 |
$0.00 |
| Z1038 |
|
81 |
77 |
$0.00 |
| 3074F |
|
470 |
425 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$0.00 |
| 3075F |
|
189 |
187 |
$0.00 |
| Z1032 |
|
79 |
79 |
$0.00 |
| 4010F |
|
180 |
159 |
$0.00 |
| 3079F |
|
213 |
205 |
$0.00 |
| 4086F |
|
55 |
49 |
$0.00 |
| X6218 |
|
34 |
33 |
$0.00 |
| 3080F |
|
39 |
38 |
$0.00 |
| 3044F |
|
60 |
58 |
$0.00 |
| 4008F |
|
116 |
103 |
$0.00 |
| 3048F |
|
18 |
17 |
$0.00 |
| 99443 |
|
24 |
24 |
$0.00 |